Coronavirus Disease 2019 (COVID-19) Research

Monday, March 30, 2020- As the need for intubation increases in U.S. cases, so does the need for a new method of safe delivery for health care works. Two Houston Methodist doctors, Steven H. Hsu, MD, and Faisal N. Masud, MD, have developed a way to bring that added safety to their co-workers. They designed the Houston Methodist Aerosol Container, or HMAC, a clear plastic box-like device that shields clinicians from expelled air when intubating a patient.

Saturday, March 28, 2020- Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. 

Thursday, March 26, 2020- As cases of coronavirus disease 2019 (COVID-19) increase and leaders across the nation put out a call for personal protective equipment for health care workers, Houston Methodist is working with its engineering partners at Texas A&M University to design a kit for creating a safe and efficient alternative to N95 masks.

Thursday, March 26, 2020- Houston Methodist Hospital is a participating site for two phase 3 clinical studies to evaluate the safety and efficacy of the Gilead Sciences pharmaceutical Remdesivir in adults diagnosed with coronavirus disease 2019 (COVID-19).

Wednesday, March 25, 2020- With the rapid onset of the coronavirus disease 2019 (COVID-19) pandemic, only limited national and international guidelines currently exist guiding approaches to treatment. In response to the urgent need for effective, evidence-based approaches, two Houston Methodist physicians are developing management strategies and measuring outcomes for treating COVID-19, an upper respiratory illness that can range in severity.

Tuesday, March 17, 2020- Houston Methodist researchers are partnering with GeneOne Life Science Inc. to develop an RNA vaccine against COVID-19, the novel coronavirus that has caused a global pandemic.